Literature DB >> 17571094

Rotavirus vaccines: recent developments and future considerations.

Juana Angel1, Manuel A Franco, Harry B Greenberg.   

Abstract

Two new vaccines have recently been shown to be safe and effective in protecting young children against severe rotavirus gastroenteritis. Although both vaccines are now marketed worldwide, it is likely that improvements to these vaccines and/or the development of future generations of rotavirus vaccines will be desirable. This Review addresses recent advances in our knowledge of rotavirus, the host immune response to rotavirus infection and the efficacy and safety of the new vaccines that will be helpful for improving the existing rotavirus vaccines, or developing new rotavirus vaccines in the future.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17571094     DOI: 10.1038/nrmicro1692

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN: 1740-1526            Impact factor:   60.633


  50 in total

Review 1.  Rotavirus diversity and evolution in the post-vaccine world.

Authors:  John T Patton
Journal:  Discov Med       Date:  2012-01       Impact factor: 2.970

2.  Prevention of the murine model of biliary atresia after live rotavirus vaccination of dams.

Authors:  Alexander J Bondoc; Mubeen A Jafri; Bryan Donnelly; Sujit K Mohanty; Monica M McNeal; Richard L Ward; Greg M Tiao
Journal:  J Pediatr Surg       Date:  2009-08       Impact factor: 2.545

3.  Qualitative and quantitative characteristics of rotavirus-specific CD8 T cells vary depending on the route of infection.

Authors:  Janina Q Jiang; Xiao-Song He; Ningguo Feng; Harry B Greenberg
Journal:  J Virol       Date:  2008-05-14       Impact factor: 5.103

Review 4.  Immune responses to rotavirus infection and vaccination and associated correlates of protection.

Authors:  Ulrich Desselberger; Hans-Iko Huppertz
Journal:  J Infect Dis       Date:  2011-01-15       Impact factor: 5.226

5.  Novel triacsin C analogs as potential antivirals against rotavirus infections.

Authors:  Yunjeong Kim; David George; Allan M Prior; Keshar Prasain; Shuanghong Hao; Duy D Le; Duy H Hua; Kyeong-Ok Chang
Journal:  Eur J Med Chem       Date:  2012-02-11       Impact factor: 6.514

6.  Human rotavirus-specific IgM Memory B cells have differential cloning efficiencies and switch capacities and play a role in antiviral immunity in vivo.

Authors:  Carlos F Narváez; Ningguo Feng; Camilo Vásquez; Adrish Sen; Juana Angel; Harry B Greenberg; Manuel A Franco
Journal:  J Virol       Date:  2012-08-01       Impact factor: 5.103

7.  Differential profiles and inhibitory effect on rotavirus vaccines of nonantibody components in breast milk from mothers in developing and developed countries.

Authors:  Sung-Sil Moon; Jacqueline E Tate; Pratima Ray; Penelope H Dennehy; Derseree Archary; Anna Coutsoudis; Ruth Bland; Marie-Louise Newell; Roger I Glass; Umesh Parashar; Baoming Jiang
Journal:  Pediatr Infect Dis J       Date:  2013-08       Impact factor: 2.129

Review 8.  Rotavirus vaccines: an overview.

Authors:  Penelope H Dennehy
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

Review 9.  Rotavirus infection.

Authors:  Sue E Crawford; Sasirekha Ramani; Jacqueline E Tate; Umesh D Parashar; Lennart Svensson; Marie Hagbom; Manuel A Franco; Harry B Greenberg; Miguel O'Ryan; Gagandeep Kang; Ulrich Desselberger; Mary K Estes
Journal:  Nat Rev Dis Primers       Date:  2017-11-09       Impact factor: 52.329

10.  Public health impact and cost effectiveness of mass vaccination with live attenuated human rotavirus vaccine (RIX4414) in India: model based analysis.

Authors:  Johnie Rose; Rachael L Hawthorn; Brook Watts; Mendel E Singer
Journal:  BMJ       Date:  2009-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.